COVID-19 disease is an infectious disease that has been spriding worldwide. The effect of this disease is more severe in some people and as scuh coushing many deaths. CRP and albumin are biomarkers known to be associated with mortality in COVID-19 patients. In addition, it has many advantages such as its usage in many hospitals and providing relatively quick results. We aimed to test the diagnostic power of the CRP / Albumin ratio in indicating severe disease in this patient group. 174 patients hospitalized between March 30 and December 31 , 2020, were included in the study. The demographic data of the patients and CRP , albumin and CRP/Albumin ratio other laboratory results were recorded by scanning the patient files. Follow-up patients with and without invasive mechanical ventilation were grouped. In comparing between the groups, the rate of two or more comorbidities was higher in the patient group who received invasive mechanical ventilation support. While the CRP value was higher in these patients, the albumin value was lower. There is a statistically significant correlation between the CRP / albumin ratio and the application of invasive mechanical ventilation support. CRP and albumin are parameters that are widely considered in the COVID-19 patient group and evaluated in the laboratory in many hospitals. The test is relatively inexpensive and easy to apply.Serum levels can change for various reasons. As these biomarkers are used alone as indicators of mortality, the CPR / albumin ratio can be considered one of the early indicators of the need for invasive mechanical ventilation in the covid-19 patient group.
___
1. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87:281–6.
2. Guo Y, Cao Q, Hong Z, at al. Y, 2020. The origin, transmission, and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7:11.
3. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;13:754.
4. Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020;50:332-4.
5. Elmaouhoub A, Dudas J, Ramadori G. Kinetics of albumin- and alphafetoprotein- production during rat liver development. Histochem Cell Biol 2007;128:431-43.
6. Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26:767-72.
7. Park JE, Chung KS, Song JH, et al. The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Critically Ill Patients. J Clin Med. 2018;7:333.
8. Coster D, Wasserman A , Fisher E , et al. Using the kinetics of C-reactive protein response to improve the differential diagnosis between acute bacterial and viral infections. Infection. 2020;48:241–8.
9. Liu Y, Yang Y, Zhang C et al. Clinical and biochemical indexes from 2019- nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63;364–74.
10. Yang AP , Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504.
11. Liu S, Luo H, Wang Y, et al. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study. BMC Infect Dis. 2020;20:584.
12. Luo Y, Xue Y, Mao L, et al. Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019. Front Med (Lausanne). 202026;7:374.
13. Mattiuzzi C, Lippi G. Serum prealbumin values predict the severity of coronavirus disease 2019 (COVID-19) J Med Virol. 2021;93:620-1.
14. Violi F, Cangemi R, Romiti RT et al. Is Albumin Predictor of Mortality in COVID-19? Antioxid Redox Signal. 2021;35:139-42.
15. Sahu BR, Kampa RK, Padhi A, et al. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta. 2020;509:91-4.
16. Liu W, Tao ZW, Lei W et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133:1032-38.
17. Kinoshita A, Onoda H, Imai N, et al. C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22:803-10.
18. Qin G, Tu J, Liu Let al. Serum Albumin and C-Reactive Protein/Albumin Ratio Are Useful Biomarkers of Crohn'sDisease Activity. MedSciMonit. 2016 Nov 16;22:4393-4400.
19. Xue G, Gan X, Wu Z, et al. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19. Int Immunopharmacol. 2020;89(PtA):107065.
20. El-Shabrawy M, Alsadik ME, El-Shafei M, et al. Interleukin-6 and C-reactive protein/albumin ratio as predictors of COVID-19 severityandmortality. Egyptian J Bronchol. 2021;1:5.